In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 33 for your search:
Cancer Type/Condition:  Lung cancer, non-small cell
Trial Type:  Prevention
Trial Status:  Closed
Sponsor of Trial:  NCI
Start Over
        Show
1.

Phase: Phase IV
Type: Prevention
Status: Completed
Age: 20 to 65
Sponsor: NCI, Other
Protocol IDs: AAAC8618, R01CA133595, NCT01050556

2.

Phase: Phase III
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: MDA-ID-91025, CLB-9293, E-91025, NCCTG-912452, RTOG-9101, SWOG-9221, I91-0001, INT-0125, NCI-P92-0014

3.

Phase: Phase III
Type: Prevention
Status: Closed
Age: 55 and over
Sponsor: NCI, Other
Protocol IDs: CAPS08-15024, R01CA129488-01A2, NCT01052051

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI
Protocol IDs: NCI-2013-00730, 2009-0804, N01CN35159, NCT01021215

5.

Phase: Phase II, Phase I
Type: Behavioral study, Prevention
Status: Closed
Age: 13 to 19
Sponsor: NCI, Other
Protocol IDs: R03-CA119712, NCT00297440

6.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 16 and over
Sponsor: NCI
Protocol IDs: MDA-DM-93018, NCI-P97-0079

7.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 18 and over
Sponsor: NCI
Protocol IDs: FCCC-94027, NCI-P97-0104

8.

Phase: Phase II
Type: Prevention
Status: Closed
Age: 40 to 74
Sponsor: NCI
Protocol IDs: BCCA-CIC-96-34, UBC-C96-0426, NCI-P97-0119

9.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 74
Sponsor: NCI, Other
Protocol IDs: CDR0000067919, BCCA-CIC-98-37, UBC-C98-0411, NCI-P00-0147, NCT00005880

10.

Phase: Phase II
Type: Prevention
Status: Completed
Age: Over 45
Sponsor: NCI, Other
Protocol IDs: CDR0000068727, P30CA016042, UCLA-0012067, NCI-G01-1966, NCT00020878

11.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 45 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271912, U01CA096134, P30CA016042, UCLA-0108074, NCT00055978

12.

Phase: Phase II
Type: Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000271915, P30CA022453, WSU-D-2405, WSU-093201MP4F, NCT00056004

13.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: 01-0279, National Cancer Institute, UCHSC-01279, NCT00084409

14.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 40 to 80
Sponsor: NCI
Protocol IDs: CDR0000487501, U01CA101204, P30CA023074, UARIZ-HSC-0353, NCT00363805

15.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Closed
Age: 21 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000495325, CCCWFU-98903, CCCWFU-BG03-538, NCT00376987

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention, Tissue collection/Repository
Status: Completed
Age: 40 to 79
Sponsor: NCI
Protocol IDs: NCI-2009-00836, CDR0000496457, MAY03-1-02, MAYO-03-1-02, P30CA015083, N01CN35000, NCT00368927

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 45 to 74
Sponsor: NCI, Other
Protocol IDs: CDR0000562055, U01CA096109, BCCA-H02-61177-A002, BCCA-R02-1177, H02-61177-A002, NCT00522197

18.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 45 to 74
Sponsor: NCI, Other
Protocol IDs: CDR0000578191, P01CA096964, BCCA-H03-61083, BCCA-R03-1083, H03-61083, NCT00573885

19.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 45 to 79
Sponsor: NCI
Protocol IDs: NCI-2009-00839, CDR0000617846, MAY06-8-01, P30CA015083, MAYO-MAY06-8-01, NCT00783705

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 50 and over
Sponsor: NCI, Other
Protocol IDs: 2005-0953, MDA-05-5-01, MDA-S262/505, MDA-2005-0953, EUDRACT-2005-004614-32, CDR0000470861, NCT00321893

21.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: Not specified
Sponsor: NCI, Other
Protocol IDs: CDR0000067923, P30CA016087, NYU-9905, NCI-P00-0151, NCT00005883

22.

Phase: Phase I
Type: Prevention
Status: Closed
Age: 18 to 70
Sponsor: NCI
Protocol IDs: KUMC-7159-97, NCI-P00-0152

23.

Phase: Phase I
Type: Prevention
Status: Completed
Age: 40 to 74
Sponsor: NCI, Other
Protocol IDs: CDR0000302633, BCCA-U98-0411, BCCA-C02-0298, NCT00061997

24.

Phase: Phase I
Type: Biomarker/Laboratory analysis, Prevention
Status: Completed
Age: 18 and over
Sponsor: NCI, Other
Protocol IDs: NCI 00L1, NU-00L1, DUMC-000346-00-2, NCI-P00-0167, NCT00006457

25.

Phase: Phase I
Type: Behavioral study, Prevention
Status: Completed
Age: 14 and over
Sponsor: NCI, Other
Protocol IDs: 15677, NCT00135265
1   
New Search